Ratios in Focus: Analyzing CuriosityStream Inc (CURI)’s Price-to-Cash and Price-to-Free Cash Flow

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, CuriosityStream Inc (NASDAQ: CURI) closed at $1.93 down -26.62% from its previous closing price of $2.63. In other words, the price has decreased by -$26.62 from its previous closing price. On the day, 1.12 million shares were traded. CURI stock price reached its highest trading level at $2.37 during the session, while it also had its lowest trading level at $1.58.

Ratios:

For a deeper understanding of CuriosityStream Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.00. For the most recent quarter (mrq), Quick Ratio is recorded 2.17 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.

On September 17, 2021, JP Morgan started tracking the stock assigning a Overweight rating and target price of $15.

BofA Securities Downgraded its Buy to Underperform on June 18, 2021, while the target price for the stock was maintained at $14.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 12 ’24 when HUBERMAN JONATHAN sold 16,848 shares for $1.67 per share. The transaction valued at 28,212 led to the insider holds 0 shares of the business.

Nikzad Michael sold 10,547 shares of CURI for $17,297 on Sep 12 ’24. The Director now owns 100,000 shares after completing the transaction at $1.64 per share. On Sep 12 ’24, another insider, HUBERMAN JONATHAN, who serves as the Director of the company, bought 16,848 shares for $1.66 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CURI now has a Market Capitalization of 105378576 and an Enterprise Value of 70349608. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.04 while its Price-to-Book (P/B) ratio in mrq is 1.72. Its current Enterprise Value per Revenue stands at 1.284 whereas that against EBITDA is 13.933.

Stock Price History:

Over the past 52 weeks, CURI has reached a high of $3.00, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -6.01%, while the 200-Day Moving Average is calculated to be 56.63%.

Shares Statistics:

For the past three months, CURI has traded an average of 279.63K shares per day and 203510 over the past ten days. A total of 53.29M shares are outstanding, with a floating share count of 29.33M. Insiders hold about 46.29% of the company’s shares, while institutions hold 7.54% stake in the company. Shares short for CURI as of 1728950400 were 393352 with a Short Ratio of 1.41, compared to 1726185600 on 410601. Therefore, it implies a Short% of Shares Outstanding of 393352 and a Short% of Float of 1.2999999.

Dividends & Splits

According to the company, the forward annual dividend rate for CURI is 0.07, from 0.05 in the trailing year. Against a Trailing Annual Dividend Yield of 0.019011406

Most Popular